225 related articles for article (PubMed ID: 12514787)
1. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles.
Fukunaga M
Hum Pathol; 2002 Dec; 33(12):1188-92. PubMed ID: 12514787
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas.
Fukunaga M
Arch Pathol Lab Med; 2004 Aug; 128(8):897-900. PubMed ID: 15270611
[TBL] [Abstract][Full Text] [Related]
3. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
Merchant SH; Amin MB; Viswanatha DS; Malhotra RK; Moehlenkamp C; Joste NE
Hum Pathol; 2005 Feb; 36(2):180-6. PubMed ID: 15754295
[TBL] [Abstract][Full Text] [Related]
4. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification.
Genest DR; Dorfman DM; Castrillon DH
J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
[TBL] [Abstract][Full Text] [Related]
6. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
7. Utility of p57 protein(KIP2) in molar disease to determine its androgenetic origin.
García-Barriola V; de Gómez MN; Dickson-González S; Figueira L; Cortés-Charry R
J Reprod Med; 2008 Jul; 53(7):476-80. PubMed ID: 18720921
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of cyclin E and p27KIP1 expression in early hydatidiform moles.
Fukunaga M
Int J Gynecol Pathol; 2004 Jul; 23(3):259-64. PubMed ID: 15213602
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization.
LeGallo RD; Stelow EB; Ramirez NC; Atkins KA
Am J Clin Pathol; 2008 May; 129(5):749-55. PubMed ID: 18426735
[TBL] [Abstract][Full Text] [Related]
12. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
Yang SM; You JF; Zhang XW; Zheng J; Liao SL
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
14. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
16. p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.
Lund H; Nielsen S; Grove A; Vyberg M; Sunde L
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):694-701. PubMed ID: 31567274
[TBL] [Abstract][Full Text] [Related]
17. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
18. Application of flow cytometry in diagnosis of hydatidiform moles.
Fukunaga M; Ushigome S; Fukunaga M; Sugishita M
Mod Pathol; 1993 May; 6(3):353-9. PubMed ID: 8346184
[TBL] [Abstract][Full Text] [Related]
19. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2.
Kihara M; Matsui H; Seki K; Nagai Y; Wake N; Sekiya S
J Reprod Med; 2005 May; 50(5):307-12. PubMed ID: 15971478
[TBL] [Abstract][Full Text] [Related]
20. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]